期刊文献+

Annexin A1 in Alzheimer’s disease:A new therapeutic strategy focusing on neuroinflammation

暂未订购
导出
摘要 Neurodegenerative diseases affect millions of people worldwide,with Alzheimer’s disease(AD)being the leading cause of dementia.It is estimated that more than 50 million people live with this condition,which is expected to triple by 2050,driven mainly by the aging of the global population(GBD 2019 Dementia Forecasting Collaborators,2022).
出处 《Neural Regeneration Research》 2026年第6期2363-2364,共2页 中国神经再生研究(英文版)
基金 funded by the São Paulo Research Foundation (FAPESP grant No. 2022/02327-6) supported by the FAPESP scholarship (2021/00270-4 and 2024/05491-7)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部